Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDK2 | Q15119 | 14/20 | 0.61 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.42 |
| ▸ | CA12 | O43570 | 1/20 | 0.41 |
| ▸ | CA1 | P00915 | 1/20 | 0.41 |
| ▸ | CA2 | P00918 | 1/20 | 0.41 |
| ▸ | CA7 | P43166 | 1/20 | 0.41 |
| ▸ | XDH | P47989 | 1/20 | 0.41 |
| ▸ | CA9 | Q16790 | 1/20 | 0.41 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4918215 | 0.89 | PDK2 (0.61) | PDK2EGFRTSHRCA12CA1 | |
| SCHEMBL18012748 | 0.84 | PDK2 (0.58) | PDK2 | |
| SCHEMBL4912255 | 0.82 | PDK2 (0.55) | PDK2ALOX5 | |
| SCHEMBL30617326 | 0.82 | PDK2 (0.44) | PDK2 | |
| SCHEMBL18012749 | 0.82 | PDK2 (0.44) | PDK2 | |
| SCHEMBL18012740 | 0.82 | PDK2 (0.44) | PDK2 | |
| SCHEMBL4910149 | 0.81 | PDK2 (0.59) | PDK2EGFRTSHRCA12CA1 | |
| SCHEMBL23614160 | 0.80 | PDK2 (0.42) | PDK2 | |
| SCHEMBL4910213 | 0.79 | PDK2 (0.68) | PDK2EGFRTSHRCA12CA1 | |
| SCHEMBL4914219 | 0.78 | PDK2 (0.63) | PDK2EGFRTSHRCA12CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10995082-B2 | Cationic photoinitiator and preparation method and use thereof | CHANGZHOU TRONLY NEW ELECTRONIC MATERIALS CO., LTD. (CN) | 2021-05-04 | — | — | US | disclosed |
| US-20190218199-A1 | NOVEL CATIONIC PHOTOINITIATOR AND PREPARATION METHOD AND USE THEREOF | CHANGZHOU TRONLY ADVANCED ELECTRONIC MATERIALS CO., LTD. (CN) | 2019-07-18 | — | — | US | disclosed |
| EP-3498691-A1 | NOVEL CATIONIC PHOTOINITIATOR, AND PREPARATION METHOD THEREFOR AND APPLICATIONS THEREOF | Changzhou Tronly New Electronic Materials Co., Ltd (CN) | 2019-06-19 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10995082-B2 | Cationic photoinitiator and preparation method and use thereof | SLC11A2, SLC7A1, PPOX | PDK2 1523/4885EGFR 3957/4885TSHR 2445/4885 |
| US-20190218199-A1 | NOVEL CATIONIC PHOTOINITIATOR AND PREPARATION METHOD AND USE THEREOF | SLC11A2, SLC7A1, PPOX | PDK2 1368/4885EGFR 4114/4885TSHR 2527/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.